Skin hyperpigmentation induced by olanzapine, a novel antipsychotic agent.
Om Parkash
OP
Jhirwal
Davinder
D
Parsad
Debashish
D
Basu
D000284:Administration, Oral; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D006229:Hand Dermatoses / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine